PRODRUGS OF DIPHENYL OX- INDOL- 2 -ONE COMPOUNDS FOR THE TREATMENT OF CANCERS
申请人:Topo Target A/S
公开号:EP2102158A1
公开(公告)日:2009-09-23
PRODRUGS OF DIPHENYL OX-INDOL-2-ONE COMPOUNDS
申请人:Christensen Mette Knak
公开号:US20100029646A1
公开(公告)日:2010-02-04
The present application discloses prodrugs of substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds having the general formula (I). The 4-position of the phenyl moieties and the N-position of the indole represent useful handles for the introduction of particular prodrug groups, in particular those comprising an amino acid moiety. The prodrug compounds are believed to be useful for the treatment of cancer in a mammal, possibly in combination with one or more other chemotherapeutic agents. The application also discloses the compounds for use in a method of treating a mammal suffering from or being susceptible to cancer
[EN] PRODRUGS OF DIPHENYL OX- INDOL- 2 -ONE COMPOUNDS FOR THE TREATMENT OF CANCERS<br/>[FR] PRO-MÉDICAMENTS DE COMPOSÉS DIPHÉNYL OX-INDOL-2-ONE POUR LE TRAITEMENT DE CANCERS
申请人:TOPOTARGET AS
公开号:WO2008071387A1
公开(公告)日:2008-06-19
[EN] The present application discloses prodrugs of substituted 3,3-diphenyl-l,3-dihydro-indol-2-one compounds having the general formula (I). The 4-position of the phenyl moieties and the N -position of the indole represent useful handles for the introduction of particular prodrug groups, in particular those comprising an amino acid moiety. The prodrug compounds are believed to be useful for the treatment of cancer in a mammal, possibly in combination with one or more other chemotherapeutic agents. The application also discloses the compounds for use in a method of treating a mammal suffering from or being susceptible to cancer. [FR] La présente invention concerne des pro-médicaments de composés 3,3-diphényl-1,3-dihydro-indol-2-one substitués. La position 4 des groupements phényle et la position N de l'indole représentent des points d'attache utiles pour l'introduction de groupes pro-médicaments particuliers, en particulier ceux comprenant un groupement acide aminé. Les composés pro-médicaments sont censés être utiles dans le traitement du cancer chez un mammifère, éventuellement en association avec un ou plusieurs autres agents chimiothérapiques. L'invention concerne également des composés destinés à être utilisés dans un procédé de traitement d'un mammifère souffrant du cancer ou susceptible d'avoir le cancer.